Triple Crown Ventures

Triple Crown Ventures
Date: 2025
Deal: Acquisition of majority stake in Cannovum Health.
About the client: TCV is a specialist vehicle established to invest in and acquire businesses across the medical cannabis value chain.
About the transaction: Akur advised TCV on the acquisition of a majority stake in Cannovum Health, a licensed distributor of medical cannabis products in Germany.
Lead: David Shapton
<img alt=

Triple Crown Ventures

Triple Crown Ventures
Date: 2025
Deal: Investment into GROW Group plc
About the client: TCV is a specialist vehicle established to invest in and acquire businesses across the medical cannabis value chain.
About the transaction: Akur advised TCV on its investment into GROW Group plc, a licensed distributor of medical cannabis products in the UK, Germany and Australia.
Lead: David Shapton
<img alt=

Triple Point Energy Transition plc

Triple Point Energy Transition plc
Date: March 2025
Deal: Financial Adviser – Public to take private
About the client: Triple Point Energy Transition plc (“TENT”), an investment company, listed on the London Stock Exchange, investing in a diversified portfolio of assets contributing to energy transition, including hydro, grid scale battery storage, and CHP.
About the transaction: Akur, on behalf of the Board of Directors, undertook a review of the strategic options available to TENT in November 2023, resulting in a Board decision to proceed with a take private via asset realisation – leading to a managed wind-down of the company. Akur led the process on behalf of the Board, from seeking shareholder approvals, through advising on the return of value to shareholders following the asset realisations.
Lead: Siobhan Sergeant
Ardian

« Older Entries